Inhibition of polyamine synthesis reduces the growth rate and delays the expression of differentiated phenotypes in primary cultures of embryonic mesoderm from chick.
Inhibition of polyamine synthesis in early chick embryos blocks their development at gastrulation. Analyses of arrested embryos show that mesodermal outgrowth and differentiation are drastically impaired. To study these effects in greater detail, we have used primary cultures of embryonic mesoderm from chick. The cultures were treated with alpha-difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase, the first and rate-limiting enzyme in polyamine synthesis. In control culture medium, mesodermal cells retained their in ovo outgrowth behavior and differentiation pattern. Addition of 10 mM DFMO to the culture medium, however, retarded attachment and outgrowth, and reduced the rate of proliferation of the mesodermal cells. Furthermore, the expression of differentiated phenotypes, such as beating heart tissue, erythroid cells, and adipocyte-like cells, was delayed. Simultaneous addition of 100 microM putrescine prevented or reduced the effects of DFMO, showing that these were indeed caused by polyamine deficiency. In the DFMO-treated mesoderm, DNA synthesis was markedly suppressed by the first day. Similar effects on RNA and protein synthesis developed at a later time. Our data suggest that a reduction in the concentrations of the polyamines decreases the rate of mesodermal cell proliferation, and as a consequence delays the expression of differentiated phenotypes.
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002642:Chick Embryo; D000518:Eflornithine / Q000494:pharmacology*; D006454:Hemoglobins / Q000032:analysis; D007700:Kinetics; D008648:Mesoderm / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D065108:Ornithine Decarboxylase Inhibitors; D010641:Phenotype; D011073:Polyamines / Q000096:biosynthesis*; D011509:Proteoglycans / Q000096:biosynthesis; D011700:Putrescine / Q000494:pharmacology; D013464:Sulfuric Acids / Q000096:biosynthesis; D010959:Tissue Plasminogen Activator / Q000032:analysis
D006454:Hemoglobins; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; D011509:Proteoglycans; D013464:Sulfuric Acids; D010959:Tissue Plasminogen Activator; D011700:Putrescine; D000518:Eflornithine